Assignee
UNIV REGENSBURG
DE·16 granted patents·14 pending applications·12 citations·filing 2012–2025
Top patents by PatentIndex Score
30 records- 0184US10106540B2HDAC6 inhibitors and their usesUNIV REGENSBURG·Filed 2015·Granted Oct 23, 2018·6 cites·14 claims
- 0282US11191855B21,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereofUNIV REGENSBURG·Filed 2016·Granted Dec 7, 2021·2 cites·20 claims
- 0377US11078266B2Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3UNIV REGENSBURG·Filed 2016·Granted Aug 3, 2021·2 cites·8 claims
- 0468US12338280B2Antibodies targeting IL3UNIV REGENSBURG·Filed 2025·Granted Jun 24, 2025·0 cites·18 claims
- 0567US2025382362A1Antibodies targeting il3UNIV REGENSBURG·Filed 2025·Application pending·0 cites
- 0666US11938233B21,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereofUNIV REGENSBURG·Filed 2021·Granted Mar 26, 2024·0 cites·9 claims
- 0766US9714286B2Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodiesUNIV REGENSBURG·Filed 2013·Granted Jul 25, 2017·1 cites·14 claims
- 0864US10768167B2Plasma membrane citrate transporter for use in the diagnosis and treatment of cancerUNIV REGENSBURG·Filed 2015·Granted Sep 8, 2020·1 cites·2 claims
- 0960US9938343B2Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodiesUNIV REGENSBURG·Filed 2017·Granted Apr 10, 2018·0 cites·3 claims
- 1059US12247973B2Plasma membrane citrate transporter for use in the diagnosis and treatment of cancerUNIV REGENSBURG·Filed 2020·Granted Mar 11, 2025·0 cites·5 claims
- 1153US2024374554A1Isoflavone derivatives modulating mutant bestrophin 1 for treatment of best1-related retinopathiesUNIV REGENSBURG·Filed 2022·Application pending·0 cites
- 1252US2024125782A1Liposome-receptor-assayUNIV REGENSBURG·Filed 2021·Application pending·0 cites
- 1351US2023143825A1A nanoparticle for use in the treatment of an ocular diseaseUNIV REGENSBURG·Filed 2021·Application pending·0 cites
- 1451US2024402119A1Carbon nanofiber electrodes for flow-through electrochemical sensorsUNIV REGENSBURG·Filed 2022·Application pending·0 cites
- 1550US9822176B2IL-3 antibodies and their use in diagnosis and treatment of diseases or malfunctions associated with elevated levels of IL-3UNIV REGENSBURG·Filed 2013·Granted Nov 21, 2017·0 cites·12 claims
- 1650US2022409743A1Virus-mimetic nanoparticlesUNIV REGENSBURG·Filed 2020·Application pending·0 cites
- 1749US2021324281A1Fuel derived from renewable resourcesUNIV REGENSBURG·Filed 2019·Application pending·0 cites
- 1848US12590323B2Compositions for use in treating autosomal dominant BEST1-related retinopathiesUNIV REGENSBURG·Filed 2021·Granted Mar 31, 2026·0 cites·25 claims
- 1948US2022213204A1Cd25-specific chimeric antigen receptors and their usesUNIV REGENSBURG·Filed 2020·Application pending·0 cites
- 2044US2024335504A1Non-human bactericidal/permeability-increasing protein (bpi) for therapy of infectionsUNIV REGENSBURG·Filed 2022·Application pending·0 cites
- 2143US12478605B2Biochanin a derivatives for treatment of BEST1-related retinopathiesUNIV REGENSBURG·Filed 2021·Granted Nov 25, 2025·0 cites·17 claims
- 2242US2023009145A1Inhibition of tmem16a by benzbromarone or niclosamide for treating polycystic kidney disease and/or polycystic liver diseaseUNIV REGENSBURG·Filed 2020·Application pending·0 cites
- 2341US2021283110A1Compound for use in the treatment of a disease characterized by dysregulated mucus production and/or secretionUNIV REGENSBURG·Filed 2019·Application pending·0 cites
- 2440US2020292529A1New drug screening assay using regulatory macrophagesUNIV REGENSBURG·Filed 2018·Application pending·0 cites
- 2534US11198694B2HDAC6 inhibitors, with improved solubility and their usesUNIV REGENSBURG·Filed 2018·Granted Dec 14, 2021·0 cites·14 claims
- 2634US2014348772A1Production of hydrogels by means of diels-alder reactionUNIV REGENSBURG·Filed 2012·Application pending·0 cites
- 2732US12527862B2Bactericidal/permeability increasing protein for use in a method of immunization, preferably as an adjuvant in a method of vaccinationUNIV REGENSBURG·Filed 2019·Granted Jan 20, 2026·0 cites·12 claims
- 2832US11384076B2Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitorsUNIV REGENSBURG·Filed 2018·Granted Jul 12, 2022·0 cites·22 claims
- 2929US10514358B2Method and device for two-dimensional separation of ionic speciesUNIV REGENSBURG·Filed 2015·Granted Dec 24, 2019·0 cites·12 claims
- 3029US2019111168A1Photosensitizer dispersion, and use thereofUNIV REGENSBURG·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →